CD163 Monoclonal Antibody Modified Polymer Prodrug Nanoparticles for Targeting Tumor-Associated Macrophages (TAMs) to Enhance Anti-Tumor Effects
Tumor-associated macrophages (TAMs)-based immunotherapy is a promising strategy. Since TAMs are mainly composed of M2-type macrophages, they have a promoting effect on tumor growth, invasion, and metastasis. M2-type macrophages contain a specific receptor CD163 on their surface, providing a prerequi...
Saved in:
Main Authors: | Zun Yang (Author), Haijiao Li (Author), Wenrui Zhang (Author), Mingzu Zhang (Author), Jinlin He (Author), Zepeng Yu (Author), Xingwei Sun (Author), Peihong Ni (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CD163 versus CD68 in tumor associated macrophages of classical hodgkin lymphoma
by: Harris Jonathan A, et al.
Published: (2012) -
Immunotherapies Targeting Tumor-Associated Macrophages (TAMs) in Cancer
by: Mei-Ye Li, et al.
Published: (2024) -
Haptoglobin Genotype-Dependent Anti-Inflammatory Signaling in CD163+ Macrophages
by: R. Clive Landis, et al.
Published: (2013) -
Relationship of Tumor-Associated Macrophage Population Detected by CD68 PG-M1, CD68 KP1, and CD163 with Latent EBV Infection and Prognosis in Classical Hodgkin Lymphoma
by: Hanife Seda MAVILI, et al.
Published: (2021) -
Relationship Between sCD163 and mCD163 and Their Implication in the Detection and Typing of Leprosy
by: Farag AGA, et al.
Published: (2020)